<DOC>
	<DOCNO>NCT00500279</DOCNO>
	<brief_summary>To evaluate effect celecoxib use 3 month drug-eluting stent implantation - restenosis - clinical outcome target lesion revascularization , thrombotic event , myocardial infarction , death - inflammatory biomarkers</brief_summary>
	<brief_title>Effects Celecoxib On Restenosis After Coronary Intervention Evolution Atherosclerosis Trial</brief_title>
	<detailed_description>Restenosis major adverse effect coronary stent implantation . Drug-eluting stent markedly reduce restenosis compare bare-metal stent , restenosis still main cause repeat coronary intervention drug-eluting stent implantation . After coronary stent implantation , inflammatory reaction occur vessel wall vascular smooth muscle cell proliferate . Celecoxib well know anti-proliferative effect well anti-inflammatory effect , safety drug well-established . Celecoxib use 6 month paclitaxel-eluting stent implantation significantly reduce neointimal growth repeat intervention without increase adverse effect . Because inflammatory reaction seem occur early period vessel injury , reduce use celecoxib may also effective .</detailed_description>
	<mesh_term>Coronary Restenosis</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>angina pectoris positive stress test native coronary artery lesion feasible drugeluting stent implantation acute recent ST segment elevation myocardial infarction ( within four week ) leave main coronary artery disease hepatic dysfunction ( AST ALT &gt; 120 IU/L ) renal dysfunction ( serum creatinine &gt; 2.0 mg/dl ) severe congestive heart failure ( NYHA class &gt; 2 ) leave ventricular ejection fraction &lt; 30 % hemodynamically unstable condition definite intracoronary thrombus contraindication history allergy aspirin , clopidogrel , celecoxib warfarin use expect survival less two year due medical condition patient already take COX3 inhibitor NASIDS</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Drug-eluting stent</keyword>
	<keyword>Restenosis</keyword>
	<keyword>Celecoxib</keyword>
</DOC>